0001558370-19-002436 Sample Contracts

COLLABORATION AND LICENSE AGREEMENT BY AND AMONG ARGENX BVBA AND ARGENX SE (SOLELY FOR PURPOSES OF SECTIONS 16.2 AND 16.3) AND CILAG GMBH INTERNATIONAL

Collaboration and License Agreement • March 26th, 2019 • Argenx Se • Biological products, (no disgnostic substances) • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  March 26th, 2019
• Company
  Argenx Se
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Collaboration and License Agreement (the “Agreement”) is made and effective as of December 2, 2018 (the “Execution Date”) by and between argenx BVBA, a Belgian company (“argenx”) and, solely for purposes of Sections 16.2 and 16.3, argenx SE, a Societas Europaea (“Parent”), on the one hand, and Cilag GmbH International, a Swiss company (“Janssen”), on the other hand.

INVESTMENT AGREEMENT Between argenx SE and Johnson & Johnson Innovation – JJDC, Inc. (the Agreement)

Investment Agreement • March 26th, 2019 • Argenx Se • Biological products, (no disgnostic substances)

• Contract Type
  Investment Agreement
• Filed
  March 26th, 2019
• Company
  Argenx Se
• Industry
  Biological products, (no disgnostic substances)

Admission means the admission to trading of the Investment Securities on the regulated market Euronext Brussels organised by Euronext Brussels NV/SA;